Jones Financial Companies
XBIT icon

Jones Financial Companies’s XBiotech XBIT Stock Holding History

Jones Financial Companies’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$840 Hold
370
– – ﹤0.01% 4393
2025
Q4 		$884 Hold
370
– – ﹤0.01% 4053
2025
Q3 		$999 Hold
370
– – ﹤0.01% 3898
2025
Q2 		$1.04K Hold
370
– – ﹤0.01% 3652
2025
Q1 		$1.15K Sell
370
-1,207
-77% -$4.16K ﹤0.01% 3370
2024
Q4 		$6.23K Buy
+1,577
New +$10.7K ﹤0.01% 2691

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jones Financial Companies's XBIT Position: Q1 2026 in Review

Jones Financial Companies held its XBiotech (XBIT) position steady in Q1 2026 at 370 shares worth $840. The position accounts for ﹤0.01% of the portfolio, ranked #4393.

Jones Financial Companies first reported a position in XBIT in Q4 2024 and has held it in 6 quarters since. The position peaked at $6.23K in Q4 2024. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.

  • Jones Financial Companies held 370 shares of XBiotech worth $840 as of Q1 2026.
  • Jones Financial Companies left its XBiotech share count unchanged in Q1 2026.
  • XBiotech made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4393 holding.
  • Jones Financial Companies first reported a position in XBiotech in Q4 2024 and has held it in 6 quarters since.
  • Jones Financial Companies's XBiotech position peaked at $6.23K in Q4 2024.
  • 37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.